Florida College Newswire (Page 2)

Florida College Newswire (Page 2)

Comprehensive Real-Time News Feed for Florida College. (Page 2)

Results 21 - 40 of 1,635 in Florida College

  1. AMAG Pharmaceuticals to Host Conference Call on August 9, 2016 at...Read the original story

    Thursday Jul 21 | P&T Community

    ... www.amagpharma.com . Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug ...

    Comment?

  2. AMAG Pharmaceuticals to Host Conference Call on August 9, 2016 at...Read the original story

    Thursday Jul 21 | P&T Community

    ... www.amagpharma.com . Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug ...

    Comment?

  3. PAINWeek Presents New Program on Pain Management in the EDRead the original story w/Photo

    Wednesday Jul 20 | PRWeb

    ... and Pediatrics, and Assistant Chair for Research, at the Department of Emergency Medicine, at University of Florida College of Medicine/Jacksonville. The track, presented on Tuesday, September 6, will include these sessions: Child Life 101 for ...

    Comment?

  4. North Florida Community College is Recognized as a Great Place to WorkRead the original story w/Photo

    Wednesday Jul 20 | WTXL

    ... ts, health and wellness programs, an outstanding benefits package, and professional collaboration within the Florida College System and beyond."

    Comment?

  5. Respected Jacksonville, FL Prosthodontist, Dr. Kathryn Ryan, Unveils...Read the original story w/Photo

    Wednesday Jul 20 | PRWeb

    ... University School of Dentistry, and is a Fellowship trained in implant surgery from the University of Florida College of Dentistry. Dr. Ryan is a member of the American Dental Association, International Team for Implantology, Northeast District ...

    Comment?

  6. Sucampo Announces Second Quarter 2016 Earnings CallRead the original story

    Wednesday Jul 20 | P&T Community

    ... [email protected] Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was ...

    Comment?

  7. Report: Pediatric Asthma Costs Vary Widely Across HospitalsRead the original story

    Tuesday Jul 19 | P&T Community

    ... Silber said. Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was very ...

    Comment?

  8. FDA Updates Label for Darunavir (Prezista) in Pregnant Women With HIVRead the original story

    Monday Jul 18 | P&T Community

    ... or compliance. Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was very ...

    Comment?

  9. Dean to Receive the Nation's Top Academic Pharmacy Research AwardRead the original story w/Photo

    Monday Jul 18 | Health News Digest

    J ulie Johnson, Pharm.D. , dean of the University of Florida College of Pharmacy , will be honored next week with the top research award presented by the American Association of Colleges of Pharmacy, or AACP. The Volwiler Research Achievement Award recognizes Johnson for her contributions to the field of pharmacogenomics, the study of how genes affect a person's response to drugs.

    Comment?

  10. Oklahoma Business PeopleRead the original story w/Photo

    Saturday Jul 16 | NewsOK.com

    ... and obstetrics and gynecology. He completed a fellowship in maternal-fetal medicine at the University of Florida College of Medicine, Gainesville, where he also completed his residency and earned a master of science degree in clinical investigation. ...

    Comment?

  11. Current issueRead the original story

    Saturday Jul 16 | P&T Community

    ... and plaque psoriasis Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug ...

    Comment?

  12. Students will get help to file aid forms, graduate sooner with associate degreesRead the original story w/Photo

    Friday Jul 15 | St. Petersburg Times

    ... go because they don't fill out the form." Troy Miller, assistant director for research and policy with the Florida College Access Network, said the FAFSA effort will help his group collect data on how many 12th grade students complete the form on a ...

    Comment?

  13. INC Research Schedules Second Quarter 2016 Earnings Call for Thursday, July 28th, 2016Read the original story

    Friday Jul 15 | P&T Community

    ... Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was very effective ...

    Comment?

  14. FDA Staff Says Suicide Risk With Psoriasis Drug Brodalumab Is Difficult to AssessRead the original story

    Friday Jul 15 | P&T Community

    ... challenging." Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was very ...

    Comment?

  15. Zika Epidemic Likely to End Within Three Years, Research SuggestsRead the original story

    Friday Jul 15 | P&T Community

    ... need," he said. Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was ...

    Comment?

  16. Q2 2016: Continued healthy growth and a transforming acquisitionRead the original story

    Friday Jul 15 | P&T Community

    ... visit www.probi.se. Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was ...

    Comment?

  17. Interim report January-June 2016: Strong financial performance during the periodRead the original story

    Friday Jul 15 | P&T Community

    ... sh wording prevails. Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about

    Comment?

  18. Dr. Kenneth Blum Recognized by Marquis Who's Who for Excellence in Pharmacology and NeuroGeneticsRead the original story w/Photo

    Thursday Jul 14 | 24-7 Press Release

    ... at Wake Forest University School of Medicine. He is currently a volunteer research professor at the Florida College of Medicine. He is also volunteer Professor in the Department of Psychiatry University of Vermont, and appointed Adjunct Professor in ...

    Comment?

  19. Cytokinetics to Announce Second Quarter Results on July 28, 2016Read the original story

    Thursday Jul 14 | P&T Community

    ... Exchange Commission. Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug ...

    Comment?

  20. CellaVision AB: Interim Report January-June 2016Read the original story

    Thursday Jun 30 | P&T Community

    ... as expected. Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was very ...

    Comment?